Vistagen Therapeutics, Inc.
Vistagen is a biopharmaceutical company focused on developing and commercializing innovative treatments for mental health and neurological disorders. They are developing a new class of intranasal product candidates called "pherines." Their mission is to improve standards of care in anxiety and depression.
Officiellt Register
AI Kvalitetsanalys
Förtroendepoäng Detaljer
Snabblänkar
Webbplats Höjdpunkter
🌟 Liknande Pålitliga Företag
OKYO Pharma Ltd
OKYO Pharma Ltd. (NASDAQ:OKYO) is a biopharmaceutical company dedicated to developing an innovative treatment for neuropathic corneal pain and dry eye disease. Through its proprietary chemerin peptide, OK-101, the company aims to provide targeted therapy that alleviates pain, controls inflammation, and enhances ocular residence time for more effective, lasting relief.
Phathom Pharmaceuticals, Inc.
Phathom Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing new treatments for gastrointestinal (GI) diseases, particularly acid-related disorders. They have licensed exclusive rights in the United States, Europe, and Canada to a potassium-competitive acid blocker (PCAB). Phathom is committed to transforming the treatment landscape and improving the lives of patients.
UroGen Pharma Ltd.
UroGen Pharma is a biopharmaceutical company focused on developing and commercializing innovative treatments for urologic cancers. They utilize RTGel® technology for sustained local delivery of medications to the urinary tract. Their key products include Jelmyto® and Zusduri™, representing advancements in uro-oncology treatment.